Company news

Manzo Pharmaceuticals, Inc. (OTC:MNZO) news

Manzo Pharmaceuticals, Inc. news releases on 6ix. Latest, Feb 24, 2022: Shareholder Meeting

View Manzo Pharmaceuticals, Inc. →

Press releases & updates

Shareholder Meeting

February 23, 2022

Virtual Special Meeting

February 22, 2022

SEC Suspension of Trading

March 9, 2018

New Manzo Pharmaceuticals, Inc. Website

October 31, 2016

Manzo Pharmaceuticals, Inc announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.

July 29, 2016

Manzo Pharmaceuticals solidifies deal with USA based manufacturers to begin producing the company's lactose intolerance probiotic, Lacto-Freedom

March 24, 2016

Manzo Pharmaceuticals Gets Remarkable Results On Human Study Of Lacto-Freedom™ For Lactose Intolerance As The Company Prepares For Production

February 16, 2016

Manzo Pharmaceuticals starts human laboratory testing of the company's lactose intolerance probiotic, Lacto-Freedom™

October 15, 2015

Manzo Pharmaceuticals announces exciting new product release as the company prepares for the full-scale human study of its Lacto-Freedom product to begin

June 8, 2015

Manzo Pharmaceuticals Announces Plans for Human Clinical Studies of the Company's Patented Lactose Intolerance Probiotic, Lacto-Freedom™

March 11, 2015

Manzo Pharmaceuticals announces progress, as retail stores start to carry Tummy Relief.

March 9, 2015

Manzo Pharmaceuticals Announces Positive Results From Laboratory Study of Lacto-Freedom Probiotic

February 3, 2015

Manzo Pharmaceuticals begins retail distribution of products with independent pharmacies

November 12, 2014

Manzo Pharmaceuticals gets confirmation that Lacto-Freedom probiotic is a dietary supplement and will not need FDA approval

October 7, 2014

Manzo Pharmaceuticals announces successful results in laboratory tests of its lactose intolerance probiotic Lacto-Freedom

September 29, 2014

Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective

September 17, 2014

Fortune Oil and Gas announces name change and plans to improve share structure

June 30, 2014

Manzo Pharmaceuticals announces the release of its newest product Tummy Relief a natural colic remedy for babies

June 17, 2014

Manzo Pharmaceuticals starts laboratory testing of its lactose intolerance probiotic treatment

June 16, 2014

Fortune Oil & Gas announces major change in business direction with the acquisition of Manzo Pharmaceuticals

June 11, 2014